Select Page

MEDICA:  Undisputedly the world’s most important trade show and gathering place for the medical industry worldwide.  Americans have long been a driving force behind both the quality and size of this event, on average featuring over 500 US-based companies occupying about 2 acres (or about 1½ US football fields!) of exhibit space at the Düsseldorf fairgrounds.

Over the past decade in particular, mobile, IoT and big data has emerged as perhaps the most revolutionizing dynamic in the medical industry marketplace, and the US med-tech industry not surprisingly continues to dominate the global landscape.  Some industry reports suggest digital health market revenues here may surpass $150 billion within the next 5-7 years.

In tandem, FTR4H FUTURE FOR HEALTH is an international platform powered by MEDICA that has risen alongside to highlight wireless and digital technologies – showcasing and exploring how digital transformation is affecting and will continue to drive important developments in the healthcare industry.

And now for the first time, the USA Pavilion at MEDICA 2017 will also feature a FTR4H LAB showcasing innovators and visionaries in this field.

The first company to join the FTR4H LAB is Westlake, Ohio based Blue Spark Technologies, Inc.  A pioneering developer of thin, flexible, printed power solutions,  Blue Spark Technologies’ latest innovation, TempTraq®, is the only Bluetooth® wearable continuous temperature monitor in the form of a soft patch that can continuously and comfortably monitor body temperature for up to 72 hours, sending real-time temperature data to a Hospital’s Nurse Monitoring Stations, EHR, and Smart Devices.  With TempTraq’s new TempTraq Connect HIPAA-complaint Cloud, it can also be used remotely and enable a hospital to monitor patients at home in real time.

TempTraq has been tested in the most demanding environments at leading hospitals including Cleveland Clinic, University Hospital’s Seidman Cancer Center and Akron Children’s Hospital and has been clinically proven to detect fever 30 – 180 minutes earlier than a 4 Hour SOC in trials with Bone Marrow Transplant Patients (Abstracts available upon request).   TempTraq is an FDA cleared Class 2 Medical Device and by November and MEDICA, the device will be CE approved and available for both Consumer and Clinical markets in Europe.

For more information about TempTraq®, plan to visit them at MEDICA 2017 – hall 16 / stand C20-6 or contact Blue Spark Technologies / VP of Sales, Mr. John Baragar jbaragar@bluesparktechnologies.com

For more information about joining the FTR4H LAB in the USA Pavilion at MEDICA 2017, contact Messe Düsseldorf North America / Sr. Business Development Manager, Mr. Ryan Klemm rklemm@mdna.com